bso cancer glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression Targeting the Vulnerability of Glutathione
Targeting the Vulnerability of Glutathione Metabolism in ARID1A Deficient Cancers ScienceDirect Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor 2 Expressing Pre Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu DOTATATE Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF B and MAPK signaling pathways Glutathione Dependent Pathways in Cancer Cells
Pay in 4 interest-free payments of $7.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23



